Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients
ConditionMulti Drug Resistant Organisms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorValeriu Gheorghita
About this trial
This study aims to evaluate the impact of digestive carriage of multidrug-resistant organisms (MDRO) on the risk of healthcare-associated infections in hospitalized adult patients. Patients will be screened at admission, weekly, and at discharge, with a 30-day post-discharge follow-up. The findings will support infection prevention and control strategies in Romanian hospitals.
Eligibility criteria
Qualifiers
18 years
Disqualifiers
withdrawal
Trial design
Treatments tested in this trial
- MDRO Rectal Screening
- 30-Day Telephone Follow-Up
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Valeriu Gheorghita
Lead sponsor
Emergency and Clinical Hospital "Dr. Agrippa Ionescu"
Sponsor institution
Source ClinicalTrials.gov